175 related articles for article (PubMed ID: 10669102)
1. Comparative distribution of ivermectin and doramectin to parasite location tissues in cattle.
Lifschitz A; Virkel G; Sallovitz J; Sutra JF; Galtier P; Alvinerie M; Lanusse C
Vet Parasitol; 2000 Feb; 87(4):327-38. PubMed ID: 10669102
[TBL] [Abstract][Full Text] [Related]
2. Comparative plasma disposition kinetics of ivermectin, moxidectin and doramectin in cattle.
Lanusse C; Lifschitz A; Virkel G; Alvarez L; Sánchez S; Sutra JF; Galtier P; Alvinerie M
J Vet Pharmacol Ther; 1997 Apr; 20(2):91-9. PubMed ID: 9131534
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic evaluation of four ivermectin generic formulations in calves.
Lifschitz A; Sallovitz J; Imperiale F; Pis A; Jauregui Lorda J; Lanusse C
Vet Parasitol; 2004 Jan; 119(2-3):247-57. PubMed ID: 14746983
[TBL] [Abstract][Full Text] [Related]
4. Moxidectin in cattle: correlation between plasma and target tissues disposition.
Lifschitz A; Virkel G; Imperiale F; Sutra JF; Galtier P; Lanusse C; Alvinerie M
J Vet Pharmacol Ther; 1999 Aug; 22(4):266-73. PubMed ID: 10499239
[TBL] [Abstract][Full Text] [Related]
5. Doramectin concentration profiles in the gastrointestinal tract of topically-treated calves: Influence of animal licking restriction.
Sallovitz JM; Lifschitz A; Imperiale F; Virkel G; Larghi J; Lanusse C
Vet Parasitol; 2005 Oct; 133(1):61-70. PubMed ID: 15994007
[TBL] [Abstract][Full Text] [Related]
6. Comparative plasma dispositions of ivermectin and doramectin following subcutaneous and oral administration in dogs.
Gokbulut C; Karademir U; Boyacioglu M; McKellar QA
Vet Parasitol; 2006 Feb; 135(3-4):347-54. PubMed ID: 16280198
[TBL] [Abstract][Full Text] [Related]
7. Bioequivalence of ivermectin formulations in pigs and cattle.
Lifschitz A; Pis A; Alvarez L; Virkel G; Sanchez S; Sallovitz J; Kujanek R; Lanusse C
J Vet Pharmacol Ther; 1999 Feb; 22(1):27-34. PubMed ID: 10211714
[TBL] [Abstract][Full Text] [Related]
8. Ivermectin disposition kinetics after subcutaneous and intramuscular administration of an oil-based formulation to cattle.
Lifschitz A; Virkel G; Pis A; Imperiale F; Sanchez S; Alvarez L; Kujanek R; Lanusse C
Vet Parasitol; 1999 Oct; 86(3):203-15. PubMed ID: 10511102
[TBL] [Abstract][Full Text] [Related]
9. Plasma pharmacokinetics and faecal excretion of ivermectin, doramectin and moxidectin following oral administration in horses.
Gokbulut C; Nolan AM; McKellar QA
Equine Vet J; 2001 Sep; 33(5):494-8. PubMed ID: 11558745
[TBL] [Abstract][Full Text] [Related]
10. Plasma dispositions of ivermectin, doramectin and moxidectin following subcutaneous administration in rabbits.
Gokbulut C; Biligili A; Kart A; Turgut C
Lab Anim; 2010 Apr; 44(2):138-42. PubMed ID: 19959569
[TBL] [Abstract][Full Text] [Related]
11. Comparative assessment of different ivermectin and doramectin formulations for mange control in grazing steers.
Canton C; Muchiut S; Dominguez MP; Lanusse C; Alvarez LI; Lifschitz A
Vet Parasitol; 2023 Apr; 316():109891. PubMed ID: 36780819
[TBL] [Abstract][Full Text] [Related]
12. Plasma pharmacokinetics and faecal excretion of ivermectin (Eqvalan paste) and doramectin (Dectomax, 1%) following oral administration in donkeys.
Gokbulut C; Boyacioglu M; Karademir U
Res Vet Sci; 2005 Dec; 79(3):233-8. PubMed ID: 16054893
[TBL] [Abstract][Full Text] [Related]
13. Pattern of ivermectin (sheep) and doramectin (cattle) residues in muscular tissue from various anatomical locations.
Moreno L; Alvarez L; Ceballos L; Bruni SS; Lanusse C
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2008 Apr; 25(4):406-12. PubMed ID: 18348039
[TBL] [Abstract][Full Text] [Related]
14. The comparative serum disposition kinetics of subcutaneous administration of doramectin, ivermectin and moxidectin in the Australian Merino sheep.
Barber S; Bowles V; Lespine A; Alvinerie M
J Vet Pharmacol Ther; 2003 Oct; 26(5):343-8. PubMed ID: 14633186
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of doramectin and ivermectin after oral administration in horses.
Pérez R; Cabezas I; Godoy C; Rubilar L; Muñoz L; Arboix M; Castells G; Alvinerie M
Vet J; 2002 Mar; 163(2):161-7. PubMed ID: 12093191
[TBL] [Abstract][Full Text] [Related]
16. Ivermectin (3.15%) long-acting formulations in cattle: absorption pattern and pharmacokinetic considerations.
Lifschitz A; Virkel G; Ballent M; Sallovitz J; Imperiale F; Pis A; Lanusse C
Vet Parasitol; 2007 Jul; 147(3-4):303-10. PubMed ID: 17524559
[TBL] [Abstract][Full Text] [Related]
17. A detailed assessment of the pattern of moxidectin tissue distribution after pour-on treatment in calves.
Sallovitz JM; Lifschitz A; Imperiale F; Virkel G; Lanusse C
J Vet Pharmacol Ther; 2003 Dec; 26(6):397-404. PubMed ID: 14962050
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the efficacy of subcutaneously administered ivermectin, doramectin, and moxidectin against naturally infected Toxocara vitulorum in calves.
Avcioglu H; Balkaya I
Trop Anim Health Prod; 2011 Aug; 43(6):1097-9. PubMed ID: 21350848
[TBL] [Abstract][Full Text] [Related]
19. Disposition of doramectin milk residues in lactating dairy sheep.
Imperiale FA; Mottier L; Sallovitz JM; Lifschitz AL; Lanusse CE
J Agric Food Chem; 2003 May; 51(10):3185-90. PubMed ID: 12720413
[TBL] [Abstract][Full Text] [Related]
20. Measurement of ivermectin concentrations in target worms and host gastrointestinal tissues: influence of the route of administration on the activity against resistant Haemonchus contortus in lambs.
Lloberas M; Alvarez L; Entrocasso C; Virkel G; Lanusse C; Lifschitz A
Exp Parasitol; 2012 Jul; 131(3):304-9. PubMed ID: 22575734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
